Foot & Ankle Research and Innovation Lab (FARIL), Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Foot & Ankle Research and Innovation Lab (FARIL), Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Foot Ankle Surg. 2024 Aug;30(6):524-528. doi: 10.1016/j.fas.2024.04.006. Epub 2024 Apr 17.
In this randomized clinical trial, we compared the early effects of polyethylene (PE), polyurethane (PU), and Carbon Fiber insoles in the treatment of PF using a set of patient-reported outcomes.
Patients were randomly allocated one of the three prefabricated insoles - Carbon Fiber (n = 14), PU (n = 14), or PE (n = 17) for regular use. Their response was recorded using PROMIS 3a (for pain intensity), PROMIS 4a (for pain interference), FAOS (Foot and Ankle Outcome Score), and VAS for pain at baseline, two, six, and twelve weeks.
The PROMIS pain intensity scores improved in both the Carbon Fiber and the PE groups starting at the 6th week (p = 0.04) and 2nd week (p = 0.002), respectively. PROMIS pain interference scores also showed positive trends in these two groups (p = 0.02, p = 0.004, respectively).
Prefabricated Carbon Fiber and PE insoles showed significant pain-reducing effects in patients with PF.
Level I, Randomized controlled trial.
在这项随机临床试验中,我们使用一组患者报告的结果比较了聚乙烯(PE)、聚氨酯(PU)和碳纤维鞋垫在治疗 PF 中的早期效果。
将患者随机分配到三种预制鞋垫中的一种 - 碳纤维(n = 14)、PU(n = 14)或 PE(n = 17)进行常规使用。使用 PROMIS 3a(用于疼痛强度)、PROMIS 4a(用于疼痛干扰)、FAOS(足部和踝关节结局评分)和 VAS 在基线、2 周、6 周和 12 周记录他们的反应。
从第 6 周(p = 0.04)和第 2 周(p = 0.002)开始,碳纤维和 PE 组的 PROMIS 疼痛强度评分均有所改善。这两组的 PROMIS 疼痛干扰评分也呈现出积极的趋势(分别为 p = 0.02、p = 0.004)。
预制碳纤维和 PE 鞋垫在 PF 患者中显示出显著的止痛效果。
I 级,随机对照试验。